265 related articles for article (PubMed ID: 22811260)
1. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
2. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
Dalsgaard S; Nielsen HS; Simonsen M
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
[TBL] [Abstract][Full Text] [Related]
3. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
4. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2012 Oct; 68(10):1443-50. PubMed ID: 22434389
[TBL] [Abstract][Full Text] [Related]
5. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S
Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886
[TBL] [Abstract][Full Text] [Related]
6. Patterns and profiles of methylphenidate use both in children and adults.
Pauly V; Frauger E; Lepelley M; Mallaret M; Boucherie Q; Micallef J
Br J Clin Pharmacol; 2018 Jun; 84(6):1215-1227. PubMed ID: 29512177
[TBL] [Abstract][Full Text] [Related]
7. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
8. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
9. The use of melatonin in Swedish children and adolescents--a register-based study according to age, gender, and medication of ADHD.
Furster C; Hallerbäck MU
Eur J Clin Pharmacol; 2015 Jul; 71(7):877-81. PubMed ID: 25995170
[TBL] [Abstract][Full Text] [Related]
10. The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
Grimmsmann T; Himmel W
Eur J Clin Pharmacol; 2021 Jan; 77(1):107-115. PubMed ID: 32803292
[TBL] [Abstract][Full Text] [Related]
11. Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.
Pottegård A; Bjerregaard BK; Kortegaard LS; Zoëga H
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):349-53. PubMed ID: 25220739
[TBL] [Abstract][Full Text] [Related]
12. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
13. ADHD Medication Trends in Turkey: 2009-2013.
Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
[TBL] [Abstract][Full Text] [Related]
14. Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.
Ormhøj SS; Pottegård A; Gasse C; Rasmussen L
Br J Clin Pharmacol; 2018 Jul; 84(7):1505-1513. PubMed ID: 29493809
[TBL] [Abstract][Full Text] [Related]
15. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
16. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
[TBL] [Abstract][Full Text] [Related]
17. Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015.
Mac Avin M; Teeling M; Bennett KE
BMJ Open; 2020 Apr; 10(4):e035716. PubMed ID: 32327478
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Norum J; Olsen AI; Nohr FI; Heyd A; Totth A
Glob J Health Sci; 2014 Apr; 6(4):155-62. PubMed ID: 24999151
[TBL] [Abstract][Full Text] [Related]
19. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
Štuhec M; Locatelli I; Švab V
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
Garbe E; Mikolajczyk RT; Banaschewski T; Petermann U; Petermann F; Kraut AA; Langner I
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):452-8. PubMed ID: 23234588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
